Clinical Trials Directory

Trials / Unknown

UnknownNCT03248076

Effect of Fentanyl on Main Opioid Receptor (OPRM1) on Human Granulosa Cells.

Effect of Fentanyl on Expression of Main Opioid Receptor (OPRM1) on Human Granulosa Cells During Ultrasound-guided Transvaginal Oocyte Retrieval.

Status
Unknown
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
George Papanicolaou Hospital · Academic / Other
Sex
Female
Age
18 Years – 32 Years
Healthy volunteers
Accepted

Summary

Opioids is known that produce not only analgesia but also hyperalgesia through activation of central glutaminergic system-GABA. At the same time, recently it was found that the main opioid receptor (OPRM1) is present on human granulosa cells and exogenous opiates and their antagonists can influence granulosa cell vascular endothelial growth factor (VEGF) production via OPRM1, causing ovarian hyperstimulation syndrome. This study aims to investigate if a single exposure to opioids is enough to produce activation of stress mechanism during oocyte retrieval.

Detailed description

The main opioid receptor (OPRM1) is present on human granulosa cells and exogenous opiates and their antagonists can influence granulosa cell vascular endothelial growth factor (VEGF) production via OPRM1, causing ovarian hyperstimulation syndrome. This study aims to investigate if a single exposure to opioids is enough to produce activation of stress mechanism during ultrasound-guided oocyte retrieval. It will be measured the level of cortisone before and 15min after iv administration of fentanyl on blood and on oocyte fluid.

Conditions

Interventions

TypeNameDescription
DRUGFentanyl Citrate1γ/Kg fentanyl

Timeline

Start date
2017-04-01
Primary completion
2018-08-31
Completion
2018-10-10
First posted
2017-08-14
Last updated
2017-12-14

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT03248076. Inclusion in this directory is not an endorsement.